Evidence map›Paper›PMID 30402240›Full record

ArticleNew microbes and new infections2018

Malaria, tuberculosis and HIV: what's new? Contribution of the Institut Hospitalo-Universitaire Méditerranée Infection in updated data.

Lionel Almeras, Leonardo K Basco, Cheikh Sokhna, Stéphane Ranque, Philippe Parola, Christian Devaux, Philippe Brouqui, Michel Drancourt, Bruno Pradines

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in New microbes and new infections, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Lionel AlmerasUnité Parasitologie et entomologie, Département des maladies infectieuses, Institut de recherche biomédicale des armées, Institut Hospitalo-Universitaire (IHU)-Méditerranée Infection, Marseille, France.
Leonardo K BascoAix-Marseille Université, IRD, AP-HM, SSA, VITROME, Marseille, France.
Cheikh SokhnaAix-Marseille Université, IRD, AP-HM, SSA, VITROME, Marseille, France.
Stéphane RanqueAix-Marseille Université, IRD, AP-HM, SSA, VITROME, Marseille, France.
Philippe ParolaAix-Marseille Université, IRD, AP-HM, SSA, VITROME, Marseille, France.
Christian DevauxAix-Marseille Université, IRD, AP-HM, MEPHI, IHU-Méditerranée Infection, Marseille, France.
Philippe BrouquiAix-Marseille Université, IRD, AP-HM, MEPHI, IHU-Méditerranée Infection, Marseille, France.
Michel DrancourtAix-Marseille Université, IRD, AP-HM, MEPHI, IHU-Méditerranée Infection, Marseille, France.
Bruno PradinesUnité Parasitologie et entomologie, Département des maladies infectieuses, Institut de recherche biomédicale des armées, Institut Hospitalo-Universitaire (IHU)-Méditerranée Infection, Marseille, France.
Aix-Marseille Université · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Institut Hospitalo-Universitaire Méditerranée Infection is positioned for the diagnosis, prevention and treatment of the 'big three' killer diseases: malaria, tuberculosis and HIV. We implemented the use of new diagnostic samples such as stools and new diagnostic tests such as mass spectrometry for the dual identification of vectors and pathogens. Furthermore, advances in the prevention and treatment of malaria and tuberculosis are reviewed, along with advances in the understanding of the role of microbiota in the resistance to HIV infection. These achievements represent a major step towards a better management of the 'big three' diseases worldwide.

Indexed as

DiagnosticdrugsHIVmalariamicrobiotaMycobacterium tuberculosisPlasmodium falciparumresistancetuberculosisvector

Identifiers

PMID30402240
PMCPMC6205578
OpenAlexW2832486363

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.